To scrutinize the role of TFCs' pyroptosis in HT development, pyroptosis inhibitors VX-765 (Caspase-1 inhibitor) (Sun et al. 2020) and disulfiram (GSDMD inhibitor) (Hu et al. 2020) were employed. The gene discussed is GSDMD; the disease is hematocrit.